» Articles » PMID: 29636374

Mutational Signatures of DNA Mismatch Repair Deficiency in and Human Cancers

Overview
Journal Genome Res
Specialty Genetics
Date 2018 Apr 12
PMID 29636374
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Throughout their lifetime, cells are subject to extrinsic and intrinsic mutational processes leaving behind characteristic signatures in the genome. DNA mismatch repair (MMR) deficiency leads to hypermutation and is found in different cancer types. Although it is possible to associate mutational signatures extracted from human cancers with possible mutational processes, the exact causation is often unknown. Here, we use genome sequencing of and knockouts to reveal the mutational patterns linked to MMR deficiency and their dependency on endogenous replication errors and errors caused by deletion of the polymerase ε subunit Signature extraction from 215 human colorectal and 289 gastric adenocarcinomas revealed three MMR-associated signatures, one of which closely resembles the MMR spectrum and strongly discriminates microsatellite stable and unstable tumors (AUC = 98%). A characteristic difference between human and MMR deficiency is the lack of elevated levels of NG > NTG mutations in likely caused by the absence of cytosine (CpG) methylation in worms The other two human MMR signatures may reflect the interaction between MMR deficiency and other mutagenic processes, but their exact cause remains unknown. In summary, combining information from genetically defined models and cancer samples allows for better aligning mutational signatures to causal mutagenic processes.

Citing Articles

Deep Learning for Biomarker Discovery in Cancer Genomes.

Unger M, Loeffler C, Zigutyte L, Sainath S, Lenz T, Vibert J bioRxiv. 2025; .

PMID: 39829845 PMC: 11741323. DOI: 10.1101/2025.01.06.631471.


Investigating the origins of the mutational signatures in cancer.

Boysen G, Alexandrov L, Rahbari R, Nookaew I, Ussery D, Chao M Nucleic Acids Res. 2025; 53(1).

PMID: 39778866 PMC: 11707540. DOI: 10.1093/nar/gkae1303.


Adaptive Significance of Non-coding RNAs: Insights from Cancer Biology.

McDonald J Mol Biol Evol. 2025; 42(1).

PMID: 39761690 PMC: 11725524. DOI: 10.1093/molbev/msae269.


Mutational signature analysis predicts bacterial hypermutation and multidrug resistance.

Hall K, Williams L, Smith R, Kuang E, Ernst R, Bojanowski C Nat Commun. 2025; 16(1):19.

PMID: 39746975 PMC: 11695600. DOI: 10.1038/s41467-024-55206-w.


Structural and Dynamical Properties of Nucleic Acid Hairpins Implicated in Trinucleotide Repeat Expansion Diseases.

Pan F, Xu P, Roland C, Sagui C, Weninger K Biomolecules. 2024; 14(10).

PMID: 39456210 PMC: 11505666. DOI: 10.3390/biom14101278.


References
1.
Stephens P, Tarpey P, Davies H, Van Loo P, Greenman C, Wedge D . The landscape of cancer genes and mutational processes in breast cancer. Nature. 2012; 486(7403):400-4. PMC: 3428862. DOI: 10.1038/nature11017. View

2.
Brouwer J, Willemsen R, Oostra B . Microsatellite repeat instability and neurological disease. Bioessays. 2009; 31(1):71-83. PMC: 4321794. DOI: 10.1002/bies.080122. View

3.
Shlien A, Campbell B, De Borja R, Alexandrov L, Merico D, Wedge D . Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers. Nat Genet. 2015; 47(3):257-62. DOI: 10.1038/ng.3202. View

4.
Alexandrov L, Nik-Zainal S, Wedge D, Campbell P, Stratton M . Deciphering signatures of mutational processes operative in human cancer. Cell Rep. 2013; 3(1):246-59. PMC: 3588146. DOI: 10.1016/j.celrep.2012.12.008. View

5.
Miyaki M, Konishi M, Tanaka K, Muraoka M, Yasuno M, Igari T . Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet. 1997; 17(3):271-2. DOI: 10.1038/ng1197-271. View